N EURAL cell adhesion molecules (NCAMs) represent a family of cell surface glycoproteins involved in the autoadhesion between NCAM-expressing cells. The temporal and spatial patterns of NCAM expression in derivatives of the germ layers in developing vertebrates led to the hypothesis that NCAM-mediated selective adhesion plays a critical role in a number of morphogenetic events (1). While NCAMs are transiently present in a variety of tissues during embryonic development, NCAMs in the adult are found mainly in neural, muscle, and endocrine cells (1, 2). Three different major NCAM protein isoforms have been characterized. The two large NCAM isoforms, with apparent molecular masses of 180 and 140 kilodaltons, span the plasma membrane and contain large or small cytoplasmic domains, respectively. The small NCAM isoform (120 kilodaltons) is anchored to the plasma membrane via phosphatidylinositol (3) (4) (5) . At least 20 major exons code for the different NCAM isoforms. The leader sequence is encoded by exon 0 (6) (7) (8) . Exons l-14 are used to generate the extracellular domain of all three polypeptides. Exon 15 codes for the membrane anchoring sequence of NCAM-120 as well as for the NCAM-120-specific 3'-noncoding region. Exons 16, 17 , and 19 characterize both NCAM-140 and -180, whereas exon 18 codes for an additional cytoplasmic insert unique to NCAM-180 (9) (10) (11) (12) .
Recently, additional exons in the NCAM gene have been discovered in the NCAM cDNA. A 108-basepair (bp) insert, termed MSDl (muscle-specific domain l), located between exons 12 and 13 (splice site a) was found in a cDNA clone derived from human skeletal muscle (13) and was shown to be composed of three small exons of 15, 48, and 42 bp and a 3'-AAG triplett adjacent to exon 13 (14) . These alternative exons can be used in various combinations (e.g. ex12-ex13, ex12-a15-ex13, and ex12-a15-a48-a42-ex13); the resulting NCAM transcripts may contain, in addition, the AAG trinucleotide (6, (15) (16) (17) . NCAM messengers containing these alternative or extra exons in splice site a are not restricted to skeletal muscle and have also been identified in heart (15, 18) and brain tissue (6, 17) . Alternative splicing has been observerd at the exon 7/8 splice junction of NCAM. At this site, a 30-bp extra sequence, termed variable alternatively spliced exon (VASE) in the rat or r in the mouse (6, 19) , was found. Its translation product changes the structure of the fourth immunoglobulin (Ig)-like domain (20) . If all different combinations identified so far were translated, up to 192 different NCAM proteins could be generated (17) . The function of most of these variants is unknown. However, one exactly defined NCAM species, namely NCAM-140-containing VASE, has recently been found to down-regulate neurite outgrowth (20) .
NCAMs can also be posttranslationally modified by such mechanisms as sulfation, phosphorylation, myristinylation, and sialylation. Modulation of adhesion arises from differences in the lengths of homopolymers of cu-(2,8)-linkedneuraminic acid units (polysialic acid or PSA) (21, 22) prob-immunocytochemical data were substantiated by results of in situ hybridization histochemistry. Specifically, higher levels of NCAM mRNA were detected in the adrenal cortex than in the medulla, In the N EURAL cell adhesion molecules (NCAMs) represent a family of cell surface glycoproteins involved in the autoadhesion between NCAM-expressing cells. The temporal and spatial patterns of NCAM expression in derivatives of the germ layers in developing vertebrates led to the hypothesis that NCAM-mediated selective adhesion plays a critical role in a number of morphogenetic events (1). While NCAMs are transiently present in a variety of tissues during embryonic development, NCAMs in the adult are found mainly in neural, muscle, and endocrine cells (1, 2). Three different major NCAM pro tein isoforms have been characterized. The two large NCAM isoforms, with apparent molecular masses of 180 and 140 kilodaltons, span the plasma membrane and contain large or small cytoplasmic domains, respectively, The small NCAM isoform (120 kilodaltons) is anchored to the plasma membrane via phosphatidylinositol (3) (4) (5) . At least 20 major exons code for the different NCAM isoforms. The leader sequence is encoded by exon 0 (6) (7) (8) . Exons 1-14 are used to genera te the extracellular domain of all three polypeptides, Exon 15 codes for the membrane anchoring sequence of NCAM-120 as weIl as for the NCAM-120-specific 3' -noncoding region, Exons 16, 17, and 19 characterize both NCAM-140 and -180, whereas ex on 18 codes for an additional cytoplasmic insert unique to NCAM-180 (9-12), pituitary, NCAM mRNA was more abundant in the anterior and intermediate lobes than in the neural lobe, The sequence of NCAM mRNAs in endocrine cells was analyzed by polymerase chain reaction and SI nuclease protection assays, We found that major exons 4-13 of the NCAM mRNA in endocrine tissues and related tumor cell lines were homologous to those in the brain, However, PCI2, RINA2, and GH3 tumor cells; normal rat pituitaries; and adrenals contained different amounts of NCAM mRNA with an alternative extra exon, termed VASE (also called 'Ir in mouse) between constitutive exons 7 and 8. In addition, in pituitaries, we detected an alternative exon in splice site a between the constitutive exons 12 and 13, termed a15 with or without an AAG triplett. These sites are thought to be important for the adhesive properties of NCAM, Therefore, these results suggest that modifications of NCAM may be important for adhesive interactions in normal and neoplastic endocrine cells, (Endocrinology 132: 1207 (Endocrinology 132: -1217 (Endocrinology 132: , 1993 Recently, additional exons in the NCAM gene have been discovered in the NCAM cDNA. A 108-basepair (bp) insert, termed MSDI (muscle-specific domain I), located between exons 12 and 13 (splice site a) was found in a cD NA clone derived from human skeletal muscle (13) and was shown to be composed of three small exons of 15, 48, and 42 bp and a 3'-AAG triplett adjacent to exon 13 (14) . These alternative exons can be used in various combinations (e.g. ex12-exl3, ex12-als-exI3, and exI2-awa48-a4rexI3); the resulting NCAM transcripts may contain, in addition, the AAG trinucleotide (6, (15) (16) (17) . NCAM messengers containing these alternative or extra exons in splice site a are not restricted to skeletal muscle and have also been identified in heart (15, 18) and brain tissue (6, 17) . Alternative splicing has been observerd at the exon 7/8 splice junction of NCAM. At this site, a 30-bp extra sequence, termed variable alternatively spliced exon (VASE) in the rat or 'Tr in the mouse (6, 19) , was found. Its translation product changes the structure of the fourth immunoglobulin (Ig)-like domain (20) . If all different combinations identified so far were translated, up to 192 different NCAM proteins could be genera ted (17) . The function of most of these variants is unknown. However, one exactly defined NCAM species, namely NCAM-140-containing V ASE, has recently been found to down-regulate neurite outgrowth (20) .
NCAMs can also be posttranslationally modified by such mechanisms as sulfation, phosphorylation, myristinylation, and sialylation. Modulation of adhesion arises from differences in the lengths of homopolymers of a-(2,8)-linkedneuraminic acid units (polysialic acid or PSA) (21,22) prob-ably linked to the fifth Ig-like domain of NCAM (23, 24) . PSA linked to NCAM appears to decrease cell adhesion, but enhances neurite outgrowth (22, 25, 26) . This indicates that VASE (see above) and PSA modulate NCAM functions in opposite directions.
Certain common properties of neurons and endocrine cells led to the investigation of NCAM expression in endocrine tissues and endocrine tumors. For example, the presence of NCAM has been demonstrated in chromaffin cells of the adrenal medulla (27, 28) , islet of Langerhans endocrine cells, and the hypophysis (27, 29) . NCAM-140 is the major isoform expressed in the rat adrenal gland, adenohypophysis, and pancreatic islets, but NCAM-180 is predominant in the neurohypophysis (27, 29) . Also, the PC12 cell line, derived from a rat adrenal medullary pheochromocytoma, predominantly expresses NCAM-140 (27, 29) in addition to NCAM-180, which is increased by treatment with NGF (30) . This isoform has been noted in rat insulinoma cells (RINA2) in addition to NCAM-140 (27) . Because of the fuctional implications associated with modifications of the extracellular portion of NCAMs, we studied the presence of PSA linked to NCAM and the exon composition of NCAM isoforms expressed by endocrine tissues and derived tumors.
Materials
and Methods
Animals
Adult 3-to 5-month-old female rats (Sprague-Dawley) were purchased from Charles River (Sulzfeld, Germany) and housed in our vivarium under standard conditions, with free access to food and water. Animals were killed by decapitation under deep CO, anesthesia, and tissues were immediately removed and processed, as described below.
Cell cultures
Cell cultures of PC12 and RINA2 were grown under standard conditions in 60-mm plastic dishes (Greiner, Nurtingen, Germany). In brief, ably linkcd 10 the fifth Ig-tike domai n cf NCAM (23, 24) . P5A linke<! 10 NCAM appears 10 d ecrease cell adhesion, but enhances neurite oulgrowlh (22, 25, 26) . This inclicates thai VASE (see above) and PSA modu lale NCAM functions in opposite directions. Cerlain common properties of neurons and endocrine ceHs Jed 10 the investigation of NCAM expression in endocrine tissues and endocrine tumors. For example, the' presence of NCAM has been demonslralcd in ch romaffin rells of the adrenal medulla (27, 28) , islet of Langerhans endocrine ceHs, and the hypophysis (27, 29) . NCA M· 140 is the majorisoform expressed in the ral adrenal gland, adenohypophysis, and pancreatic islets, bul NCAM-180 is predominant in the neurohypophysis (27, 29) . Also, the pe l 2 ceil line, derived from a rat adrenal medullary pheochromocytoma, predominantly expresses NCAM -140 (27, 29) in addition 10 NCAM-180, which is increased by trea tment wilh NGF (30) . This isoform A "," 11 VASE has been notcd in rat insulinoma cells (RINA2) in addition 10 NCAM-I4 0 (27) . Because of the fuctionaI implications associated with modifica lions of the exlr3cell ular porlion of NCAMs, we sludied the presence of PSA linked 10 NCAM and Ihc exon composilion of NCAM isoforms expresse<! by cndocrinc lissues and dcrivcd tumors.
Mate ri als a nd Me thods

Animah
Adult 3-to S-month-old {emale rats (S prague-Dawley) were pur· chascd {rom Charles River (Sull.feld, Germany) and housed in our vivarium under standard condi tion~, with free access to f<JOd and water. AnimaIs were killed by decapitation under deep CO l anesthesia. and tissues were immediately removed and processed, as described below.
Cell cultures
Cell cultu res of rC I 2 and RlNA2 were grown under standard oonditions in 60-mm plastic dishes (Greiner, Nurtingen, Germany). ln brief, T he cell membra ne is indkated by the dark oox, foll/)',l.·oo by the C-Ierminal cytoplasmic part of NCAM . The posi tion of VASE betwten exons 7 and 9. which encode the fourth Ig-like domain. is shown. Part of the rat cDNA sequenCl:! of exons 7 and 9 ia gi~·en. Oligonucleotide f.'7 5'·ACTCTGACATGTGAAGCCTC-3' is identical to the senSE! orientation, wh ile oligonucleotide E95' -GTGAACAT · CACCTGTGAGGT·3' is antisense to the rat NCA M mRNA (19) . B, NCAM mRNA with extra exon VASE is presem in pituitar)". adrenal!;. and endoc rine tumo r cells. RNA sampIes and and cDNAs were prepared from the indicated tissues and endoc rine tumor cells, and p e Rs we re pe rformed (see Materials and Methods). The radioactively labeled PCR reacl ion prorluclS were separated on 7.5% nondenaturing polyacrylamide gels. The producu of 307 bases (without VASE) and 337 bases (with VASE; aslerisk) are indkated. The experiment was repealed fOUT t.imes with similar results. 5' n p ·labeled f ite marker pBRJ22 digested with Hpall was applied to lane I. PC12 cells were grown in Dulbecco's Modified Eagle's Medium (Biochrom Beteiligungs GmbH, Berlin, Germany), and RINA2 cells were grown in RPMI-1640 medium (Biochrom Beteiligungs GmbH, Berlin, Germany). GH, cell cultures were grown under serum-free conditions in Dulbecco's Modified Eagle's Medium (Biochrom Beteiligungs GmbH, Berlin, Germany) and Ham's nutrient mixture F-12 (Sigma, Deisenhofen, Germany) and, in addition, supplemented with insulin, transfetin, sodium selenite (Sigma), 10 nM TB, 15 mu HEPES, 0.5 mg/ml BSA, and 50 PM ethanolamine (Sigma). The GH, cell line (31) was kindly provided by V. Hollt (Munich, Germany), the PC12 cell line (32) was supplied by H. Thoenen (Munich, Germany), and the RINA2 cell line was provided by H. I'. T. Ammon (Tubingen, Germany). The cells were collected and washed twice in PBS, and the cell pellets were stored until needed at -2oc.
Isolation of cellular RNA, production of cDNA as template, and amplification by polymerase chain reaction (PCR)
Total RNA was isolated by a modified guanidinium thiocyanate-CsCl method (33) from rat cerebelli, adrenals and isolated adrenal cortex, pituitaries, and cell cultures of PC12, RINAZ, and GH3 cells. Total RNA was used as template for specific NCAM first strand cDNA synthesis, using the antisense 20-base oligonucleotide named E9 complementary to rat NCAM mRNA 5'-GTGAACATCACCTGTGAGGT-3'.
This oligonucleotide hybridizes in the middle of exon 9 and contains 20 bases complementary to rat NCAM mRNA [bases 1505-1524 (34); see Fig. lA ]. This oligonucleotide is also complementary to mouse NCAM cDNA (12) . Cellular RNA (0.5 rg) was used in the first strand cDNA synthesis reaction. The cDNA synthesis was carried out for 25 min at 37 C in the same reaction mix as that used for PCR amplification (see below) with 1 U AMV reverse transcriptase (Angewandte Gentechnologie Systeme, Heidelberg, Germany). Subsequently, the whole reaction mix was used directly as a template for the amplification by PCR. The antisense oligonucleotide E9 (see above) and the sense oligonucleotide E7 5'-ACTCTGACATGT-GAAGCCTC-3' were used as primers for PCR amplification. Oligonucleotide E7 has the same sequence as the protein-coding strand of the rat cDNA [bases 1187-1206 (34); see Fig. lA ]. PCR amplification (35) was performed immediately after inactivation of reverse transcriptase (95 C for 1 min) in a 50-p] reaction mix containing 10 mM Tris-HCl (pH 8.4); 50 IIU~ KCl; 2.5 mM MgClz; 0.1 rnM dithiothreitol; 0.02% gelatin (Sigma); 0.2 mM deoxy-ATP (dATP), dTTP, and dGTP; 0.1 mM dCTP; 5 PCi [a-32P]dCTP (Amersham, Dreieich, Germany); 50 pmol of each primer; and 1 U Ta9 DNA polymerase (Boehringer, Mannheim, Germany). The probes were subjected to 30 30-set cycles at 93 C, 1 min at 62 C, and 2 min at 72 C. Two-microliter aliquots were directly loaded onto nondenaturing 7.5% polyacrylamide gels in 1 X TBE buffer (TrisBorate-EDTA; 50 lll~ Tris base, 50 mM boric acid, and 1 mM EDTA). After running, the gels were dried, and the PCR products were visualized by applying the gels to x-ray films for exposure at -70 C for 1 day using intensifying screens.
The specificity of PCR products was analyzed by "cold" PCR amplification. Fifteen-microliter aliquots of the PCR reaction were separated on 2% Agarose gels (Serva, Heidelberg, Germany) in TBE buffer together with a negative (no RNA) and a positive control (NCAM cDNA clone Nl) (6) . After the run was completed, the gels were subjected to Southern transfer analysis (36) using Biodyne A membranes (0.2 pm; Pall Filtrationstechnik, Dreieich, Germany). The blots were first hybridized with an isotopically labeled cRNA probe derived from the NCAM cDNA clone Nl (6) , which contains extra exon VASE (see Fig. 2A) ; as a further control we applied hybridization with a nonoverlapping labeled cDNA probe (pM1.3) (37). PCR products were visualized by applying the Southern blots to x-ray films for exposure at -70 C for 1 or 3 days using intensifying screens. Pel2 cells were grown in Dulbe«o's Modified Eagle's Medium (Biochrom Beteiligungs GmbH, Berlin, Germany), and RINA2 cells were grown in RPMI -I640 medium (Bioc hrom Beteiligungs GmbH, Berlin. Germany). GH, cell rultur~ Wen' grown under serum-free conditions in Dulbecco's Modified Eagle's Medium (Biochrom Beteiligungs GmbH, BerHn, Germany) and Ham's nutrient mixture F-ll (Sigma. Deisenhofen, Germany) and, in addition. supplemented with insulin, trilnsferrin, sodium selenite (Sigma), 10 nM Tl< 15 IJ\M HEPES. 0.5 mg/mi BSA, and 50 , 11104 ethanolamine (Sigma). The GH) ceHline (31) was kindly provided by V. Höllt (Munich,. Germany), the PCI2 cell iine (32) was supplied by H. Thotnen (Munieh, Germany), and the RINA2 ceU Une was pruvided by H. P. T. Ammon (Tubingen, Gennany). The cells were collecled and washed twice in PBS, and the cell pellets Wen' stored until oeeded at -20 C.
NCAM DIVERSITY IN ENDOCRINE CELLS
Isolation of cellular RNA, production of eDNA as temphJte. and ampll/ieation by polymerase ehain reactilm ( p e R)
TOial RNA was isoIated by a modified guanidinium thiocyanate-CsCl method (33) from rat cerebelli, adrenals and isolated adrenal corleJe, pituitaries, and cell cultures of PCl2, RINA2, and eH) cells. Total RNA was used as template for specific NCAM first strand cDNA syn thesis, using the antisense 20· base oligonucleolide named E9 complementary to rat NCAM mRNA 5'·GTGAACATCACCTGTGAGGT-3'. Th;s oli· gonucleotide hybrid izes in the middle of exon 9 and contains 20 bases complementary to rat NCAM mRNA lhases 1505-1524 (34) (35) was performed immed.iately after inactivation of reverse transcriptase (9 5 C for 1 min) in il 50-, 111 reaction mix containing 10 m", Tris-HCI (pH 8.4); 50 IJ\M KCI; 2.5 mM MgCh; 0.1 mM dithiothreitol; 0.02% gelatin (Sigma); 0.2 ll'IM dooxy -ATP (dATP), dTIP, and dGTP; 0.1 mM dCTP; 5 ,IICi la-llP)dCTP (Amersham, Dreieich,. Cermany); 50 pmol of uch primer; and 1 U r/lq DNA polymerase (Boehri nger. Ma nnh~m, Germany). The probe$ were subjected to 30 30-sec cycles at 93 C, I min at 62 C. and 2 min at 72 C. Two-microliler aliquots were directly loaded onto nondenaluring 7.5% polyacrylamide gels in 1 x TBE buffer (Tris· Borate-fOTA: 50 mM Tris base. 50 mM boric acid. and I mM EDTA). After running. the gels were dried. and the PCR products were visualized by applying tM gels to x-ray films for exposure at -70 C for 1 day using in tensifying screens.
The specificily of PCR products was analyzed by "cold" PeR amplifialion. Fifteen -microliter aliquots of the peR reaction were separated on 2% Aga rose gels (Serva, Heidelberg. Germany) in TBE buffer logether with a negative (no RNA) and a positive control (NCAM cDNA clone N I) (6) . After Ihe run was completed, the gels were subjected to Sou them transfer analysis (36) using 8iodyne A membranes (0.2 pm; f'all Filtra· tionstechnik, Dreieich. Germany). The blots were first hybridiud with an isotopically labeled cRNA probe derived from the NCAM cDNA clone NI (6) , which contains extra e~on VASE (sei. ' Fig. 2A) ; as a further control we applied hybridization wilh a nonoverlapping labeled cDNA probe (pML3) (37) . PeR produCb were visualized by applying Ihe Southem blots 10 Je-ray films for exposure at -70 C for I or 3 days using intensifyi ng screens.
FIG. 4 cDNA and cRNA probes used for Sl nuclease protection assays and in situ hybridization histochemistry (
The mouse NCAM cDNA used for cDNA probe sythesis in this study has been previously characterized (6, 12 Fig. 2A ). Uniformly labeled single stranded cDNA probe was prepared, as previously described (38) , by use of oligonucleotide 738 (5'-CCAGA-TAGTGTCTGATG-3'), which hybridizes to nt position 2054-2070 of exon 13 (12) . The labeled primer-extended NCAM clone DW22 was digested with HindIII, yielding two fragments. These fragments were separated on 5% polyacrylamide gels (containing 8.3 M urea), and the 485.nt fragment was isolated, as previously described (38) . The purified fragment yielded was used for the Sl nuclease protection assay. The position and orientation of this fragment are given in Fig. 2A Fig. 2A ). We used this shorter cRNA probe of 243 nt to facilitate tissue penetration, As a probe for the analysis of the blotted PCR products, we used as The accuracy of amplification was also tested by restrietion analysis with thc enzyme Taql, whieh cuts within thE' extra exon VASE, thu s generating a fragment o( 9 4 nuclrotides (nt). Thcrcfore, we induded in the PCR isotopically labeled substrate, separa~d the PCR products on nondenaturing polyacrylamide gels, recovcred thc bands, and subjected them to restrietion analysis with thc restrictioo enzyme Taql. The re:sultiog isotopically labeled restriclion fragments were visualized after separation on nondenaturing polyacrylamide gels by applying thc dried gels to x-ray films.
cDNA und cRNA probes WJed tor 51 nuclease protection assays and in situ hybridization histochemistry (IS H)
The mouse NCAM cDNA used for cDNA probe sythesis in this study has been previously eharaeterized (6, 
Z).
DWn This clone is a M13 mpl9 froRI cDN A clone iwlated (rom a cDNA library o( total brain (without cerebellum) from neonatal mic .... DW22 includl.'s e~on5 10-15 (position 1635-2601) (6, 12). The probe derived thereof covers parts of exon 10. exoos 11 and 12 totally. and parts of exon 13. lt also contains the extra exon a ,,/AAG at the exon nh • 12/13 splice junction (see Fig. 2A ).
Uniformly Iabeled single stranded cDNA probe was prep'lfed, as prt'viously describt'd (38) , by use of oI igonudeotide 738 (5' -CCAGA-TAGTGTCTGATG-3'). which hybridizes to nt position 2054-2070 of ... xon 13 (12) . The labele<l primer-extended NCAM clone DWZ2 was digested with HindU!. yielding two fragments. These fragments were separate<! on 5% polyacrylamide gels (containing 8.3 M urt'a), and the 485 -nt (ragment was isolated, as previously described (38) . The purified fragment yielded was used for the SI nuc1ease protection assay. The position and orientation of this fragment are given in Fig. 2A .
As a template for cRNA synthesis. we used the cDNA clone pM!.3 in pGEM-l vector (prornega Biotec. Madison, WI). a generous gift from Dr. C. Goridis (Marseille, France) (37) .
Synthesis of l!S_labeled cRNA (SA, 8 )( 10' cpm/pg) for ISH was carried out according to the T3 polymerase protocol of Promega Biotec, using 107 pCi [<l" -)!SlCTP (SA, 37 Tera-BequereljmM) and NCAM cDNA clon e pM!.3 cut with Sau3A. The \"t'sulting cRNA probe contained Z21 nt within exons 13-14 (position 2028-2249) and 22 nt of veetor sequenees (see Fig. 2A ). We usOO this shorter cRNA probe of 243 nt to facilitate lissue renetration.
As a probe for the analysis of the blotled PCR producn;, we used as SI nuclease protection assay (Sl-NPA)
SI -NPA was carried out as dct.eribed previously (39) . Btiefly, 20 "8 total RNA (delermined photometrically) were hybridized wi th an exct'S$ of u P-labeled cDNA probe (5 x 10' cpm; SA, I x 10" cpm/ ..,g) in 75% formamide, 400 mM NaCI, I m ... EDTA. and 20 mlo.l Tris-I'ICI (pH 7.4) for 16 h olt 58 C. Hybtidlzation was t~'Tmmated by digestIon with 680 U 51 nuc1 ease (Angewandte Gentechnologie Systeme, Heidelberg, Germany) for 2 h at 37 C. After phenol e:<traction and ethanol preöpitation, sam pies weTC separaled electrophoretic.ll1y on 0.3-mm thick 5% polyacrylamide gels (8.3 M urea). Ct!ls were dri!;'<! and applied to x-ray film for exposure at -70 C for 5 days using intensifying screcn s.
ISH
Adrenals of female rats were immersed in Bouin's fixati\'e for 12 h and processed for routine paraffin embedment. Serial sections (5 "m) wt'Te cut and mounted on 3-aminopropyltricth())(ysilane-roated (Sigma) glas~ sl ides. Sections wer .. dcparaffinized, using a sequence of "ylene, ethanol, chlorofonn, and ethanol, and subsequently air dried. Pituitarit'S of f(>male rats were frozen in liquid nitrogen, and kryostat 5e(tions (7 "m) were mounted on 3-aminopropyltri('thoxysilane-coot!;'<! glass slides and fixed with 4% paraformaldl'hydl' in 0.0 I ... PBS (pH 7.3) for 30 min at room lemperatur('.
T he sections wer(> prehybridized at 50 C with hybridization solution for 3 h, as described pll'viously (39). Sub5t.-quently, they were hybridized alSO C ovemight wilh S ng labeled cRNA probe (SA, 8 x Ia' cpm/"g) in I SO " I hybridization solUlion in a humified chamber. Controls eonsisled of *,tions eilher pretreated with 100 ,l<g/ml RNase-A (Sochringer) at 37 C for 30 min ur pr~hybridizoo ovcmight at SO C with roldtranscribed antisense eRNA probe befoll' hybridizatkln with Ihe laJx>led cRNA probe. After hybridization, sections weil' washed as dl'SCTibed. To reduce background, sections weTC trcaled for 30 min at 37 C in a buffer con taining 100 "g/ml RNase-A. Afler additional washes, slides werc rinsed in ascending alcohol sol uti ons. air dried, and dipped in Ilford (Cheshire, England) K2 emulsion diluted I: 1 with HlO. They were exposcd for 3-6 wecks at 4 C and dt!veloped with Kodak 019 (Eastman Kodak, Ruchester, NY) oll 16 C for 4 ntin. The sections were counterstained ei ther with hemalaun (Mayer) and l'OSin or with giemsa solu tion and photographed with a Zeiss Axioplan photomicroscope (Oberkochen, ~rmany).
Jmm unocytochemistry
Immunocytocllemical procO'dures weTC described pll'viously 11"1 detail (39, 40)_ In brief, 5-..,m sections of Bouin's-fixed and embedded tissut'S wert' dcparaffinized and pennt!abilized for 5 min wi th Triton X-100 in PBS (10 ruM phosphate and ISO mM NaCl, pH 7. (42), a biotinylated horSt' antimouse IgG anti -$erum (1:5OO; C"mon, Wiesbaden, G(>rman y), and a oommercial avidinbiotin-peroxidase kit (Vectastain, Camon, Wiesbadl'n, Germany) weil' used with 3',3'-diaminobem:idin tl'trahydrochloride dihydrat(' as ch romogen (Aldrich, Milwaukee, \VI) . Alternatively, avidin-Iabeled nuoreseein isothiocyanate (Fluorl'SCein Avidin D, Camon, Wiesbaden. C"fmany) was uSt.'<I (1:250 to 1:1000 in 15 mM HErES, pH 7.2).
For deteclion of NCAM in cultured tumor cells, we also used a polyclonal rabbi! NCAM antiserum (43) ; direcled against the N-terminal lI -amino acid sequence ur mouS(' NCAM (LQVDIVPSQCE). wllieh was a gene rous gi ft from Dr. G. Rougon (Marseille, France). Incubations with this antibody (I: 10(0) wert' carried out ovemight.
For detection of NCAM in paraffin seetions of ral pituitary and adrenal gland, we also used IgG -likl' doma ins of the mouse NCAM (corrcsponds to position 212-1635 of cONA) (12) . Incubations with this antibody (1:500) were performed overmght. Controls ronsisted uf ommission of Ihe fir.>t antibody and incubation with rabbit serum or mouse IgC (1:500 to 1:1000). Seclions wert! examined with a Zeiss Axioplan microscope (Oberkochen, Gl'rmany). 
Results
Structure of endocrine NCAM mRNAs
Alternatively spliced extra exon VASE is present in neuroendocrine tissues and tumor cell lines of the rat. The PCR technique was chosen to determine the presence of the alternatively spliced extra exon VASE. Oligonucleotide primers downand upstream from the exon 7/B splice junction were used (Fig. 1A) . After cDNA synthesis and PCR amplification, we detected in rat pituitaries, adrenals, and the different endocrine tumor ceil lines two fragments of 307 and 337 bp, representing transcripts with and without VASE (Fig. 1B) . In the pituitary, equal amounts of VASE and non-VASE mRNAs were present, whereas in the cerebellum, VASE was 
Results
Structure 01 endocrine NCAM mRNAs
Alterna/ively spliced ex/ra exon VA SE is presen/ in neuroelldocrine tissues and tumor cel/Eines 01 the rat. The peR technique
was chosen to determine the presence of the altematively spliced extra exon VASE. Dligonudeotide primers downand upstream from the exon 7/8 splice junction were used (Fig. 1 A) . After cDNA synthesis and peR amplification, we detected in ral pituitaries, adrenals, and the different endocrine tumor cell lines two fragments of 307 and 337 bp, representing transcripts with and without VASE (Fig. 18) . In the piluitary, equal amounts of VASE and non-VASE mRNAs were present, whereas in the cerebellum, VASE was contained in most NCAM mRNAs. In contrast, adrenals contained smaller amounts of NCAM with VASE, whereas the tumor cell lines examined expressed VASE-containing transcripts to a minor extent.
The presence of VASE in the PCR products was verified by Southern blot, followed by hybridization to a labeled cRNA probe derived from cDNA clone Nl containing extra exon VASE (6) (data not shown). A nonoverlapping labeled cDNA probe (pM1.3) (37) served as a control. In addition, we carried out Sl-NPA (not shown) using a mouse brain cDNA probe (cDNA clone Nl) (6) covering exons 4-10, including VASE. Within the resolution of Sl-NPA, we found 1) identical exons 4-10 in endocrine and neural NCAMs, and 2) RNAs with and without VASE in rat pituitaries, adrenals, and the different endocrine tumor cell lines analyzed.
The accuracy of amplification was also tested by restriction analysis with the enzyme TaqI, which cuts within the extra exon VASE. The 337-nt PCR fragment (containing VASE) is cleaved within VASE, thus generating an additional fragment of 94 nt.
Alternatively
spliced extra exons at splice site a. A cDNA probe (see experimental procedures and Fig. 2A ) spanning parts of exon 10, cxons 11 and 12 totally, and parts of exon 13, including the extra exon a,,/AAG at the exon 12/13 junction, was used in Sl-NPAs to examine extracted cellular RNAs of the different endocrine rat tissues and tumor cells (Fig. 3) . A protected band of 435 nt was found in total RNA of rat cerebellum (used as control tissue) and pituitary, but not in both parts of the adrenals. This indicates that a diversity of NCAM forms exists in the pituitary with the structure ex12-alS/AAG-ex13 or ex12-a15-ex13. Two major bands of 324 and 93 nt of protected probe DNA were observed in the hybridization samples with RNAs extracted from pituitaries, adrenals, and isolated adrenal cortex. This indicates the presence of NCAM mRNAs without alternative extra exons at splice site a (Fig. 3A) . Within the resolution of Sl-NPA, insulinoma (RINA2), pheochromocytoma (X12), and the adenohypophysial tumor cell lines (GH,) were devoid of the ex12-a,J with or without AAG-ex13 arrangement in NCAM mRNA. This was demonstrated by the presence of the two major bands of 324 and 93 nt and the absence of a 435-nt band presenting full protection of the DNA probe (Fig. 3B ). An additional band of approximately 339 nt in all tissues and tumor cell lines examined might indicate the presence of exon aI5 followed by other alternatively spliced exons, such as abx and a42, with or without an AAG triplett between the exons 12 and 13 (14, 17) .
ISH and immunocytochemistry
In previous immunocytochemical studies (27, 40, 44, 45) , it was shown that NCAM is confined to the surfaces of human and rat endocrine cells. We applied ISH and used an antibody directed against the PSA epitopes linked to NCAM as well as an antibody directed against the Ig-like domains present in all three main NCAM isoforms as well as an antibody recognizing the very N-terminal part of NCAM to find out whether NCAM posttranslationally modified by sialic acid homopolymers is expressed in endocine tissues and tumor cells.
In the pituitary, the NCAM cRNA probe hybridized mainly to cells of the pars intermedia and the mixed cell population of the anterior lobe of the hypophysis, but few grains were associated with the neural lobe (Fig. 4A) . The specificity of the hybridization is documented in Fig. 4B , in which prehybridization with cold transcribed antisense cRNA abolished the specific labeling (Fig. 4A ). In the anterior lobe of the hypophysis, most of the endocrine cells were heavily labeled with the PSA antibody, but a small percentage of cells appeared to be unstained (Fig. 5A) . The immunoreactivity of the cells of the intermediate lobe was low with both the PSA antibody and the polyclonal antiserum directed against the Ig-like domains of NCAM (Fig. 5B) . The latter antiserum confirmed the presence of NCAM, especially at the cell surface of adjacent endocrine cells in the anterior lobe (Fig.  58) .
In the adrenals, NCAM mRNA and polysialylated NCAM were detected predominantly in the cortical region of the adrenals, i.e. the zona glomerulosa (I) and zona fasciculata }o'IG. 7. Detection of ,,"CAM by im munocytochemistry of astetion of the adrenal gland. As demonst rated fo r NCA M·PSA in Fig. 6 , A and C, NCAM was detected predominandy in the conical region of adrenals in zona reticula ris (111). Less NCAM was observed in the medulla (I V) with the polyc!onal antiserum directed ali8ist the Ig·like domains of NCAM. The bor equals 40 "m.
con tained in most NCA M mRNAs. [n contrasi, adrena[s contained smaller amounts of NCAM with VASE, whercas the lumor cell lines examined expressed VASE-containing Iranscripls 10 a minor exlen!. The presence of VASE in the PCR products was verified by Soulhern blot, followed by hybridization 10 a labded cRNA probe d erived from cDNA clone N I containing extra exon VASE (6) (dala not shown). A nonoverlapping labeled cDNA probe (pM 1.3) (37) servcd as a control. In addition, we carricd out S I -NPA (not shown) using a mouse b rain cDNA probe (cDNA clone NI) (6) covering exons 4-1 0, including VASE. Within the resolution of S I-NPA, we found I) identical exons 4-10 in endocrine and neural NCAMs, and 2) RNAs with and without VASE in rat pituitaries, adrenals, and the different endocrine tumor eell lines anaIyzed .
The accuracy o f amplifieation was also tested by restriction analysis with Ihe enzyme TuqJ, wh ieh euts wilhin the extra exon VASE. The 337-nt PCR fragment (containing VASE) is cleaved within VASE, thus generilting an additional frilgment of 94 nl.
A/temulively splicfd t'x/ru t'XOI1S at splice sile u. A cDNA probe (sec experimental procedurcs and Fig. 2A ) spanning paris of exon 10, cxons 11 and 12 totally, and parts of exon 13, including the extra exon al'l AAG at the exon 12/13 ju nction, was used in Sl-NPAs to examine extracted cellular RNAs of the differenl endocrine rallissues and tumor cells (Fig. 3) . A protected band o f 435 nt was found in lotal RNA of rat cerebellum (used as control tissue) ,md pituilary, bul nol in bolh paris oE Ihe adrenals. This indicales that a diversity of NCAM forms exists in the piluita ry with the structure ex l 2-a15/AAG-ex13 or exI2 -a w ex13. Two major bands of 324 and 93 nl o f prolect('d probe 1) A were observed in the hybridization sampIes with RNAs extracted from pituitaries, adrcnals, and isolated adrenal cortex. This ind icates the prt>Sence of NCAM mRNAs without alternative extra exons at spike site a (Fig. 3A) . Within thc resulution of 5 1-NPA, insulinoma (RI NA2), ph eochromoeytoma (PC1 2), and the adenohypophysialtumor celi lines (G H) were devoid of the ex 12-a l~1 with or wilhout AAG -exI3 arrangement in NCAM mRNA. This was demonstratcd by Ihe presenee of the Iwo major bands of 324 and 93 nt and the absence of a 435-nl band presenting full p rotection of the DNA probe (Fig. 38 ). An additional band o f approximately 339 nt in all tissues and tumor eell lines examined might indieate the presenee of exon al5 followOO by other alternative[y spliced exons, such as a .. ~ and a4~' with or withoul an AAG triplet! between the exons 12 and 13 (14, 17).
JSIJ (md immunocylochemistry
In previous immunocytochemieal studies (27, 40, 44, 45) , it was shown thai NCAM is confined to the surfaces of human and rat end ocri ne cells. We applied ISH and used an antibody d irected against the PSA epitopes linked to NCAM as weil as an antibody dirccted againsl the Ig-like domains prCS(>nl in all three ma in NCAM isoforms ,1S weil as an antibody recognizing the very N· terminal part of NCAM 10 find out whethe r NCAM posttranslationally modified by sialic acid homopo[ymers is exprcssed in endocine tissues and tumor cens.
In the pituitary, the NCAM cRNA probe hybridized mainly to cells of Ihe pars intermeclia and the mixed eell population oE the anlerior lobe o f the hypophysis, but few grains were associatcd with the neural lobe (Fig. 4A) . The specificily of the hybridization is documented in Fig. 48 , in which prehybridizatio n with cold transcribed antisense cRNA abolished the specific [abeling (Fig. 4A) . In the anterior lobe of the hypophysis, most o f the endocrine edls were heavily labeled wHh the PSA antibody, but a smal1 pereen tage of cel1s appeared to be unstained (Fig. SA) . The immunoreaetivity of the cells of the intermediate lobe W,1S low with both the PSA anlibody and the polyclonal a ntiserum direcled against thc Ig-likc domains of NCAM (Fig. SB) . The laller antiserum con firmed the presenee of NCAM, especially at the eell surfaee of adjacent endoeri ne cclls in Ihe anterior lobe (Fig.  SB) .
In thc adrenals, NCAM mRNA a nd polysialylated NCAM were dctected predomi nantly in Ihe cortieal region of thc adrenals, i.e. the zona gloOleru [osa (I) and zona fa scicu lata (II; Fig. 6 ). However, NCAM mRNA and polysialylated NCAM were also observed in the zona reticularis (III) and, to a lesser extent, in the adrenal medulla (IV; Fig. 6 ). A similar NCAM distribution was observed in the adrenal gland with the polyclonal antiserum directed against the Ig-like domains of NCAM (Fig. 7) . Cell clusters with stronger immunoreactivity were prominent mainly in the adrenal medulla. The tumor cell lines PC12, GH3, and RINA2 also exhibited intense NCAM and NCAM-PSA immunoreactivities, which were confined to cell surfaces and were particularly intense at contact sites between the cells (Fig. 8 ).
Discussion
Similarities in development and functional characteristics reveal a close relationship between endocrine cells and neu- (11; Fig. 6 ). However, NCAM mRNA and polysialylated NCAM were also observed in the zona reticularis (111) and, to a lesser extent, in the adrenal medulla (IV; Fig. 6) . A similar NCAM distribution was observed in the adrenal gland with the polyclonal antiserum directed against the Ig-like domains of NCAM (Fig. 7) . Cell clusters with stranger immunoreactivity were prominent mainly in the adrenal medulla . The tumorceillines PCI2, GH), and RINA2 also exhibited intense B -D NCAM and NCAM-PSA immunoreactivities, which were confined 10 cell surfaces and were particularly intense at contaet sites between the cells (Fig. 8 ).
Similarities in devdopmcnt and functional cha racteristics reveal a elose relationship between endocrine cells and neu-rons. Thus, it is not surprising that these cells have a variety of cellular constituents in common, which can be used as markers. One of the molecules expressed by both cell types is NCAM (2, 27, 44, 45) . NCAMs are involved in cell-cell interactions and are believed to play a critical role in specifying cell patterning and movement during early embryogenesis, in particular during neurogenesis. NCAMs have also been implicated in morphogenetic events in later development (13, 46) . In the present investigation, we analyzed the molecular structure of NCAM mRNA with respect to alternative splicing events as well as the distribution of posttranslationally modified NCAM in endocrine cells. We focused on recently detected alternative extra exons as well as PSA linked to NCAM, which have been recognized as functional modifications of NCAM (20, 25, 26, 47) .
The extracellular as well as intracellular parts of the NCAM molecules of endocrine cells can be modified in sequence by the molecular process of alternative splicing at the mRNA level, thus generating structurally related, but distinct, protein isoforms from a single gene. The NCAM-140 isoform prevails in endocrine cells (27, 29, 44, 45) . In the coding region for extracellular domains of NCAM, there are two sites where alternative extra exons may be included in the mRNA as a consequence of an alternative splicing event: between exons 7 and 8 (termed VASE or ir) and between exons 12 and 13 (termed the a-exons with or without the triplett AAG) (6, 15, 17, 48) . We detected different degrees of exon VASE in all endocrine tissues and related tumors examined. In accordance with a previous report (48), we found that the adult adrenal gland expresses small amounts of NCAM mRNAs that contain VASE. In the rat pituitary, the amounts of VASE-containing mRNA vs. non-VASE mRNA are balanced, whereas in the cerebellum, VASEcontaining mRNAs appeared to be more abundant (see also Ref. 48 ). The tumor cell lines expressed less of the spliced VASE variant. Exon VASE would contribute 10 additional amino acids in the fourth Ig-like domain, and this exon could be present in mRNAs coding for all three major NCAM isoforms (15) . The position of this insert of 10 amino acids within the fourth NCAM Ig-like loop is reminiscent of the position of amino acids that make up the hypervariable regions of the Ig polypeptides. Since similar sequence alterations affect the structure and function of Ig domains (49) , this alternative exon could substantially alter the ability of NCAM to mediate adhesion during development (48) . Indeed, a modification as a consequence of an alternative splicing event greatly affects the function of NCAM. It has recently been shown that alternative exon VASE downregulates the neurite outgrowth activity of NCAM-140 (20) .
It has been demonstrated that the large intron of -20 kilobases between exons 12 and 13 contains several small alternatively spliced exons (6, 14, 18) . We found that the 15 nucleotides of the extra sequences described previously (13) , termed exon al5, with or without an additional AAG triplet (6) are also present in the pituitary, but not in other tissues or cells analyzed. NCAM mRNA populations in this tissue were composed mainly of the constituitve exons ex12-ex13, i.e. with no alternative exons in between. In addition, fragments of about 339 nt observed in Sl-NPA indicate possible further modifications, such as alternative exons ad2, or a4*. In contrast to VASE (see above), the functional consequences of the insertion of alternative extra exons at the exon 12/13 splice junction, such as al5 or a48 and a42 with or without the AAG triplett in the coding region of the NCAM molecule of endocrine pituitary cells, remain to be investigated. However, the striking accumulation of three adjacent prolines in ai5 suggests that this short inserted segment may render the postulated hinge more flexible, change its angle (6) (52, 53) .
One of the most striking features of NCAM is its degree of developmentally regulated polysialylation. Posttranslationally added PSA appears to affect the homophilic binding of NCAM by altering conformation, by simple charge repulsion or direct steric hinderence (22, 25) . The amount of sialic acid decreases during development, suggesting that changes in the amount of sialic acid are used as a mechanism to modulate NCAM activity in viva (47) . The change from embryonic to adult forms of NCAM, which have less PSA (54) , occurs at different rates in different brain regions. It is delayed in the mouse cerebellar mutant, known as sfaggerer mouse, again suggesting a regulatory role (47) . Available evidence reveals a causal relationship between PSA expression and activity-dependent plasticity in the hypothalamoneurohypophyseal system (55) or during the establishment of intramuscular nerve branching (46) .
The long polysialic acid units composed of cu-(2,8)-linked N-acetylneuraminic acid units are found exclusively on NCAM in vertebrates and are not associated with other proteins (55) (56) (57) . Our observations indicate that PSA linked to NCAM is not expressed in all adenohypophyseal cells to the same extent. Low amounts of PSA linked to NCAM have been observed in the intermediate lobe, whereas, with a few exceptions, most cells of the anterior lobe were heavily stained. Most cells of the anterior lobe are acidophiles, which secrete PRL and/or GH depending on the input of hypothalamic factors and steroid hormones (58) . Therfore, the presence of heavily sialylated NCAM in the anterior lobe could be related to the cell type and/or hormonal plasticity of the pituitary cells.
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rons. Thus, it is not surprising that these ceHs have a variety of cellular constituents in common, which can be used as markers. One of the molecules expressed by both cell types is NCAM (2, 27, 44, 45) . NCAMs are involved in cell-ceH interactions and are believed to playa critical role in specifying ceH patterning and movement during early embryogenesis, in particular during neurogenesis. NCAMs have also been implicated in morphogenetic events in later development (13, 46) . In the present investigation, we analyzed the molecular structure of NCAM mRNA with respect to alternative splicing events as weil as the distribution of posttranslationally modified NCAM in endocrine cells. We focused on recently detected alternative extra exons as weil as PSA linked to NCAM, which have been recognized as functional modifications of NCAM (20, 25, 26, 47) . The extracellular as weH as intracellular parts of the NCAM molecules of endocrine cells can be modified in sequence by the molecular process of alternative splicing at the mRNA level, thus generating structuraHy related, but distinct, protein isoforms from a single gene. The NCAM-140 isoform prevails in endocrine ceHs (27, 29, 44, 45) . In the coding region for extracellular domains of NCAM, there are two sites where alternative extra exons may be inc1uded in the mRNA as a consequence of an alternative splicing event: between exons 7 and 8 (termed VASE or 71' ) and between exons 12 and 13 (termed the a-exons with or without the triplett AAG) (6, 15, 17, 48) . We detected different degrees of exon VASE in all endocrine tissues and related tumors examined. In accordance with a previous re port (48), we found that the adult adrenal gland expresses small amounts of NCAM mRNAs that contain VASE. In the rat pituitary, the amounts of VASE-containing mRNA VS. non-VASE mRNA are balanced, whereas in the cerebellum, V ASEcontaining mRNAs appeared to be more abundant (see also Ref. 48) . The tumor ceIl lines expressed less of the spliced VASE variant. Exon VASE would contribute 10 additional amino acids in the fourth Ig-like domain, and this exon could be present in mRNAs coding for all three major NCAM isoforms (15) . The position of this insert of 10 amino acids within the fourth NCAM Ig-like loop is reminiscent of the position of amino acids that make up the hypervariable regions of the Ig polypeptides. Since similar sequence alterations affect the structure and function of Ig domains (49) , this alternative exon could substantially alter the ability of NCAM to mediate adhesion during development (48) . Indeed, a modification as a consequence of an alternative splicing event greatly affects the function of NCAM. It has recently been shown that alternative exon VASE downregulates the neurite outgrowth activity of NCAM-140 (20) .
It has been demonstrated that the large intron of ~20 kilobases between exons 12 and 13 contains several sm all alternatively spliced exons (6, 14, 18) . We found that the 15 nuc1eotides of the extra sequences described previously (13) , termed exon alS, with or without an additional AAG triplet (6) are also present in the pituitary, but not in other tissues or cells analyzed. NCAM mRNA populations in this tissue were composed mainly of the constituitve exons ex12-ex13,
i.e. with no alternative exons in between. In addition, fragments of about 339 nt observed in SI-NPA indicate possible further modifications, such as alternative exons a42, or a48. In contrast to VASE (see above), the functional consequences of the insertion of alternative extra exons at the ex on 12/13 splice junction, such as alS or a48 and a42 with or without the AAG triplett in the co ding region of the NCAM molecule of endocrine pituitary cells, remain to be investigated. However, the striking accumulation of three adjacent prolines in alS suggests that this short inserted segment may render the postulated hinge more flexible, change its angle (6), or modify the possible fibronectin type III-like region encoded by ex on 12 (50) .
At present, it is not known whether NCAMs containing the sequence encoded by alS with or without AAG and all other alternative exon combinations are restricted to a certain type of endocrine ceHs in the anterior lobe or are even expressed within one cell type to distinct cell surface areas. It is worth noting at this point that examples of the presence of certain NCAM isoforms confined to distinct surface areas of epithelial and neuronal cells have been recently observed.
Powell et al. (51) demonstrated that the different isoforms of NCAM are indeed targeted to different surface areas, e.g.
NCAM-140 and -180 only to the basolateral surface of epithelial cells. On the other hand, the posphatidyl anchor of NCAM-120 serves as a targeting signal for apicallocalization. Similarly, as was demonstrated in brain tissue, NCAM-180 was concentrated at sites of cell contacts and at postsynaptic densities (52, 53) .
One of the most striking features of NCAM is its degree of developmentally regulated polysialylation. Posttranslationally added PSA appears to affect the homophilic binding of NCAM by altering conformation, by simple charge repulsion or direct steric hin deren ce (22, 25) . The amount of sialic acid decreases during development, suggesting that changes in the amount of sialic acid are used as a mechanism to modulate NCAM activity in vivo (47) . The change from embryonic to adult forms of NCAM, which have less PSA (54) , occurs at different rates in different brain regions. It is delayed in the mouse ce rebell ar mutant, known as staggerer mouse, again suggesting a regulatory role (47) . Available evidence reveals a causal relationship between PSA expression and activity-dependent plasticity in the hypothalamoneurohypophyseal system (55) or during the establishment of intramuscular nerve branching (46) .
The long polysialic acid units composed of a-(2,8)-linked N-acetylneuraminic acid units are found exc1usively on NCAM in vertebrates and are not associated with other proteins (55) (56) (57) . Our observations indicate that PSA linked to NCAM is not expressed in all adenohypophyseal cells to the same extent. Low amounts of PSA linked to NCAM have been observed in the intermediate lobe, whereas, with a few exceptions, most cells of the anterior lobe were heavily stained. Most cells of the anterior lobe are acidophiles, which secrete PRL and/or GH depending on the input of hypothalamic factors and steroid hormones (58) . Therfore, the presence of heavily sialylated NCAM in the anterior lobe could be related to the cell type and/or hormonal plasticity of the pituitary cells. Immunostaining suggested that PSA linked to NCAM is more frequent in the adrenal cortex than in the adrenal medulla. Within the cortex, the cells in the zona glomerulosa appeared to contain more of these surface components than the other parts. A similar distribution of NCAM has been noted by Poltorak (59) . The functions of adrenal cortical cells are regulated by angiotensin-II and ACTH. Furthermore, the zona glomerulosa may be regarded as a regenerative zone of the adrenal cortex (60) , and cells of the zona glomerulosa might lose NCAM immunoreactivity and PSA after migration to the zona fasciculata.
Similar to the situation in the adenohypophysis, the occurence of PSA linked to NCAM may explain the capability of the adrenal cortex to respond to a variety of physiological stimuli. A further example of the presence of PSA linked to NCAM in a system of extensive remodeling controlled by hormones is the ovary (40) . Clearly, the precise role played by PSA during remodeling remains to be investigated.
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All endocrine tumor cell lines examined exhibited strong NCAM-PSA immunoreactivities at the cell surface. The staining was seen predominantly at the contact sites between GH3 (a clonal strain of rat pituitary tumor cells), PC12 (a rat pheochromocytoma), and RINA2 (a rat insulinoma) cell lines. On the other side, these cell lines also express a low sialylated NCAM isoform (27, 29) . The combination of high sialylated as well as low sialylated NCAMs may indicate complex involvement of these different forms of NCAM in adhesion between the tumor cells. 
10.
In summary, the major findings of the present study are that NCAMs modified in several ways are present in the hypophysis and adrenals. Cells of the anterior lobe express more PSA linked to NCAM than those of the intermediate lobe. About half of the NCAM molecules present in the hypophysis appear to have an insert of 30 bp (extra exon VASE) in the region coding for the Ig-like domain IV, and further modifications at the splice site a, coding for postulated hinge region, are also evident. In the adrenal, NCAM and PSA linked to NCAM are mainly confined to the adrenal cortex. In this tissue, NCAM containing VASE US. NCAM without VASE is of low abundance, and even smaller amounts of NCAM containing VASE are present in the endocrine tumor cell lines examined. The latter express polysialylated NCAM, which is found at the cell surface predominantly at the contact sites of these cells. These results led us to conclude that these posttranscriptional and posttranslational modifications of NCAM may modulate the function of NCAMs in endocrine tissues and endocrine tumor cells in a way similar to that observed in other systems. Immunostaining suggested that PSA linked to NCAM is more frequent in the adrenal eortex than in the adrenal medulla. Within the cortex, the eells in the zona glomerulosa appeared to contain more of these surfaee components than the other parts. A similar distribution of NCAM has been noted by Poltorak (59) . The functions of adrenal eortieal eells are regulated by angiotensin-II and ACTH. Furthermore, the zona glomerulosa may be regarded as a regenerative zone of the adrenal cortex (60) , and cells of the zona glomerulosa might lose NCAM immunoreactivity and PSA after migration to the zona fasciculata. Similar to the situation in the adenohypophysis, the occurence of PSA linked to NCAM may explain the capability of the adrenal cortex to respond to a variety of physiological stimuli. A further example of the presence of PSA linked to NCAM in a system of extensive remodeling controlled by hormones is the ovary (40) . Clearly, the precise role played by PSA dudng remodeling remains to be investigated.
All endocrine tumor cel! lines examined exhibited strong NCAM-PSA immunoreaetivities at the cell surface. The staining was seen predominantly at the contact sites between GH 3 (a donal strain of rat pituitary tumor eells), PCl2 (a rat pheochromocytoma), and RINA2 (a rat insulin oma) eelllines. On the other side, these celllines also express a low sialylated NCAM isoform (27, 29) . The combination of high sialylated as well as low sialylated NCAMs may indicate eomplex involvement of these different forms of NCAM in adhesion between the tumor cells.
In summary, the major findings of the present study are that NCAMs modified in several ways are present in the hypophysis and adrenals. Cells of the anterior lobe express more PSA linked to NCAM than those of the intermediate lobe. About half of the NCAM molecules present in the hypo physis appear to have an insert of 30 bp (extra exon V ASE) in the region coding for the Ig-like domain IV, and further modifications at the splice site a, coding for postulated hinge region, are also evident. In the adrenal, NCAM and PSA linked to NCAM are mainly eonfined to the adrenal cortex. In this tissue, NCAM eontaining VASE VS. NCAM without VASE is of low abundance, and even smaller amounts of NCAM containing V ASE are present in the endocrine tumor cell lines examined. The latter express poIysialylated NCAM, which is found at the cell surfaee predominantly at the eontaet sites of these cells. These results led us to condude that these posttranscriptional and posttranslation al modifications of NCAM may modulate the function of NCAMs in endocrine tissues and endocrine tumor eells in a way similar to that observed in other systems. 
